Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 3, 2020
[Sarcopenia and Cancer Cachexia in the Treatment of Colorectal Cancer]Kazuki Nozawa
Physical Review Letters|September 28, 2010
Structure-induced covalent bonding in Al-Li compoundsKazuki Nozawa, Yasushi Ishii
Case Reports in Oncology|January 14, 2021
Dramatic Response in a Patient with Metastatic Gastric Cancer Using Trifluridine/Tipiracil after Rapid Disease Progression while on NivolumabKazuki Nozawa, Yukiya Narita, Waki Hosoda, et al.
Journal of Gastrointestinal Cancer|September 12, 2020
Salvage Chemotherapy by FOLFIRI Regimen for Poorly Differentiated Gastrointestinal Neuroendocrine CarcinomaKeiji Sugiyama, Kazuhiro Shiraishi, Mariko Sato, et al.
JCO Global Oncology|December 1, 2022
Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims DatabaseYusuke Kajimoto, Kazunori Honda, Kazuki Nozawa, et al.
In Vivo (Athens, Greece)|February 27, 2019
Primary Mediastinal HER2-positive Apocrine Carcinoma in Mature Teratoma Treated With Anti-HER2 Therapy and ChemoradiationKeiji Sugiyama, Akari Iwakoshi, Mariko Satoh, et al.
Critical Reviews in Oncology/Hematology|May 9, 2022
Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trialsKazuki Nozawa, Daiki Takatsuka, Yuka Endo, et al.
Journal of Breast Cancer|April 13, 2023
Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant ChemotherapyDaiki Takatsuka, Akiyo Yoshimura, Masataka Sawaki, et al.
Anticancer Research|July 5, 2022
Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort StudyKazuki Nozawa, Daiki Takatsuka, Yuka Endo, et al.
Asia-Pacific Journal of Clinical Oncology|September 10, 2022
Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysisDaiki Takatsuka, Masataka Sawaki, Masaya Hattori, et al.
Pageof 5